AU3876793A - Process for the inactivation of viruses in preparations of proteins - Google Patents

Process for the inactivation of viruses in preparations of proteins

Info

Publication number
AU3876793A
AU3876793A AU38767/93A AU3876793A AU3876793A AU 3876793 A AU3876793 A AU 3876793A AU 38767/93 A AU38767/93 A AU 38767/93A AU 3876793 A AU3876793 A AU 3876793A AU 3876793 A AU3876793 A AU 3876793A
Authority
AU
Australia
Prior art keywords
proteins
viruses
inactivation
preparations
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38767/93A
Inventor
Wilfried Freudenberg
Hermann Keuper
Walter Matzmorr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25915149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU3876793(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU3876793A publication Critical patent/AU3876793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04Heat
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32661Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for inactivating viruses in a solution of proteins by brief heating.
AU38767/93A 1992-05-26 1993-05-25 Process for the inactivation of viruses in preparations of proteins Abandoned AU3876793A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4217355 1992-05-26
DE4217355 1992-05-26
DE4240103A DE4240103A1 (en) 1992-05-26 1992-11-28 Process for inactivating viruses in protein preparations
DE4240103 1992-11-28

Publications (1)

Publication Number Publication Date
AU3876793A true AU3876793A (en) 1993-12-02

Family

ID=25915149

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38767/93A Abandoned AU3876793A (en) 1992-05-26 1993-05-25 Process for the inactivation of viruses in preparations of proteins

Country Status (8)

Country Link
EP (1) EP0571771B2 (en)
JP (1) JP3650410B2 (en)
KR (1) KR940005805A (en)
AT (1) ATE194648T1 (en)
AU (1) AU3876793A (en)
CA (1) CA2096888C (en)
DE (2) DE4240103A1 (en)
ES (1) ES2149791T5 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11052165B2 (en) 2015-04-20 2021-07-06 Global Life Sciences Solutions Usa Llc Method for virus clearance

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720853A1 (en) 1997-05-17 1998-11-19 Dade Behring Marburg Gmbh Increasing the FVII sensitivity of a thromboplastin reagent
NL1016029C2 (en) * 2000-08-28 2002-03-01 Gelatine Smits Beheer B V Method of eliminating disease causing agents by applying heating.
EP1337279B1 (en) * 2000-11-24 2006-06-21 Breath Limited Sterilisation of glucocorticosteriode suspensions
US11274274B2 (en) * 2015-04-20 2022-03-15 Global Life Sciences Solutions Usa Llc Inactivation of viruses
US10077646B2 (en) 2015-07-23 2018-09-18 General Electric Company Closed loop hydrocarbon extraction system and a method for operating the same
US10323494B2 (en) 2015-07-23 2019-06-18 General Electric Company Hydrocarbon production system and an associated method thereof
US10047596B2 (en) 2015-07-23 2018-08-14 General Electric Company System and method for disposal of water produced from a plurality of wells of a well-pad

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
DE3905066A1 (en) * 1989-02-18 1990-08-23 Behringwerke Ag HEAT EXCHANGER MODULE
FR2664165B1 (en) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11052165B2 (en) 2015-04-20 2021-07-06 Global Life Sciences Solutions Usa Llc Method for virus clearance

Also Published As

Publication number Publication date
EP0571771A2 (en) 1993-12-01
DE4240103A1 (en) 1993-12-02
ATE194648T1 (en) 2000-07-15
ES2149791T3 (en) 2000-11-16
KR940005805A (en) 1994-03-22
EP0571771B2 (en) 2004-10-20
EP0571771B1 (en) 2000-07-12
CA2096888C (en) 2004-04-27
ES2149791T5 (en) 2005-05-16
DE59310073D1 (en) 2000-08-17
CA2096888A1 (en) 1993-11-27
JPH0665091A (en) 1994-03-08
EP0571771A3 (en) 1994-07-06
JP3650410B2 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
AU638969B2 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
EP0675198A4 (en) Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same.
AU5557994A (en) Process for producing an undernatured whey protein concentrate
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
ITFI920078A0 (en) PROCESS FOR THE ISOLATION OF HIGHLY PURIFIED FACTOR IX, FACTOR X AND FACTOR II FROM PROTROMBIN COMPLEX OR HUMAN PLASMA.
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
AU3687593A (en) A method of producing a factor VIII preparation
FI945000A (en) Process for the preparation of (S) -3-amino-1-substituted pyrrolidines
AU561222B2 (en) Process for the pasteurization of human plasma
SG52793G (en) Process for fermentative production of 2-(4-hydroxyphenoxy-)propionic acid
AU662084B2 (en) Process for reactivating purified membrane proteins
YU49079B (en) New phospholipid derivatives and process for preration thereof
AU3380189A (en) Process for the preparation of 5-chloro-3-chlorosulphonyl-2- thiophenecarboxylic acid esters
GR3017807T3 (en) Method for inactivating biological activity of DNA.
FI960609A0 (en) Treatment process for peroxide
HUT65256A (en) Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them
RO101400B1 (en) Inactivation method for viral brushite ( bia ) vaccine
AU5463694A (en) Process for increasing the protein content of plants
AU6482190A (en) Process for the preparation of heme/hemin
AU3787393A (en) Viral inactivation method
SG84520A1 (en) Process for preparing benzyl-substituted rhodanine derivatives